,address1,address2,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Mr. John W. Huemoeller II', 'age': 67, 'title': 'Pres, CEO & Director', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 420000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
1,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Mr. Robert T. Malasek', 'age': 54, 'title': 'CFO & Sec.', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 90000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
2,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Ms. Catalina  Valencia J.D.', 'age': 73, 'title': 'Co-Founder & CEO of Sapphire Biotech, Inc.', 'yearBorn': 1949, 'fiscalYear': 2022, 'totalPay': 187500, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
3,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Mr. Kurt  Phinney', 'age': 50, 'title': 'Chief Operating Officer', 'yearBorn': 1972, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
4,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Dr. Sergei A. Svarovsky M.B.A., Ph.D.', 'title': 'Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
5,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Dr. Alim  Seit-Nebi Ph.D.', 'title': 'CTO & Co-Founder of Sapphire Biotech, Inc.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
6,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Mr. Jeffrey A. Busby', 'title': 'Sr. VP of Bus. Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
7,"6191 Cornerstone Court, East",Suite 114,San Diego,CA,92121,United States,858-923-4422,https://www.aximbiotech.com,Biotechnology,Biotechnology,Healthcare,Healthcare,"AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.",6,"{'maxAge': 1, 'name': 'Dr. Joseph  Tauber M.D.', 'age': 65, 'title': 'Chief Medical Officer & Chairman of the Medical Advisory Board', 'yearBorn': 1957, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.0282,0.0255,0.0243,0.0329,0.0282,0.0255,0.0243,0.0329,0.0,1.706085,447916,447916,319332,493310,493310,0.0,0.0,0,0,6413665,0.016,0.118,247.12614,0.02736,0.0284,0.0,0.0,USD,12036170,0.0,160404988,233648992,0.37058,0.0,233648992,-0.043,1672444800,1703980800,1688083200,-9419518,-0.05,463.768,-3.458,-0.71875,0.14113986,PNK,EQUITY,AXIM,AXIM,AXIM BIOTECHNOLOGIES INC,"AXIM Biotechnologies, Inc.",1409664600,America/New_York,EDT,2b30f2b7-de56-3e9c-9944-03bc6d08aed6,finmb_128291607,-14400000,0.02745,none,97498,0.0,-3480529,5719942,0.012,0.012,25953,0.0,-0.55712,8875,4218975,-1422283,1.0,0.0,-150.56541,USD,
